Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Stock
Equities
600671
CNE000000BF3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.41 CNY | +4.86% | 0.00% | -27.87% |
Sales 2021 | 147M 20.3M | Sales 2022 | 109M 15.03M | Capitalization | 1.16B 160M |
---|---|---|---|---|---|
Net income 2021 | -29M -4M | Net income 2022 | -67M -9.25M | EV / Sales 2021 | 8.06 x |
Net Debt 2021 | 91.41M 12.61M | Net Debt 2022 | 73.65M 10.16M | EV / Sales 2022 | 11.3 x |
P/E ratio 2021 |
-37.4
x | P/E ratio 2022 |
-17.3
x | Employees | 371 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.72% |
1 day | +4.86% | ||
Current month | -7.99% | ||
1 month | -3.00% | ||
3 months | -24.57% | ||
6 months | -19.13% | ||
Current year | -27.87% |
Managers | Title | Age | Since |
---|---|---|---|
Xu Yu Xu
CEO | Chief Executive Officer | 46 | 23-09-26 |
Hong Jian Yu
DFI | Director of Finance/CFO | 46 | 23-09-26 |
Guo Jun Dang
BRD | Director/Board Member | 37 | 21-05-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hua Cheng
BRD | Director/Board Member | 55 | 91-12-31 |
Guo Jun Dang
BRD | Director/Board Member | 37 | 21-05-25 |
Hong Jian Yu
DFI | Director of Finance/CFO | 46 | 23-09-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 8.41 | +4.86% | 784,701 |
24-04-23 | 8.02 | -2.08% | 415,201 |
24-04-22 | 8.19 | +3.02% | 1,302,016 |
24-04-19 | 7.95 | -4.90% | 1,175,301 |
24-04-18 | 8.36 | -0.59% | 429,400 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-27.87% | 141M | |
+25.61% | 660B | |
+23.69% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+13.28% | 219B | |
-9.82% | 196B | |
+6.87% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- 600671 Stock